A detailed history of Becker Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Becker Capital Management Inc holds 4,388 shares of LLY stock, worth $3.28 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
4,388
Previous 4,153 5.66%
Holding current value
$3.28 Million
Previous $3.76 Million 3.38%
% of portfolio
0.13%
Previous 0.13%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$772.14 - $960.02 $181,452 - $225,604
235 Added 5.66%
4,388 $3.89 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $18,846 - $23,635
26 Added 0.63%
4,153 $3.76 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $10,659 - $14,261
18 Added 0.44%
4,127 $3.21 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $131,822 - $155,401
-251 Reduced 5.76%
4,109 $2.4 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $119,977 - $165,406
-276 Reduced 5.95%
4,360 $2.34 Million
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $8,067 - $10,786
-23 Reduced 0.49%
4,636 $2.17 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $375,862 - $441,432
1,210 Added 35.08%
4,659 $1.6 Million
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $13,505 - $15,736
-42 Reduced 1.2%
3,449 $1.26 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $25,793 - $29,394
-87 Reduced 2.43%
3,491 $1.13 Million
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $234,455 - $291,368
999 Added 38.74%
3,578 $1.03 Million
Q4 2021

Feb 08, 2022

SELL
$224.85 - $279.04 $45,419 - $56,366
-202 Reduced 7.26%
2,579 $712,000
Q3 2021

Oct 14, 2021

SELL
$221.6 - $272.71 $73,792 - $90,812
-333 Reduced 10.69%
2,781 $643,000
Q2 2021

Aug 12, 2021

BUY
$180.55 - $233.54 $11,013 - $14,245
61 Added 2.0%
3,114 $715,000
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $164 - $212
1 Added 0.03%
3,053 $570,000
Q4 2020

Feb 10, 2021

BUY
$130.46 - $172.63 $10,175 - $13,465
78 Added 2.62%
3,052 $515,000
Q3 2020

Nov 09, 2020

SELL
$146.22 - $169.13 $14,183 - $16,405
-97 Reduced 3.16%
2,974 $440,000
Q2 2020

Aug 11, 2020

BUY
$136.42 - $164.18 $54,567 - $65,672
400 Added 14.98%
3,071 $504,000
Q4 2019

Feb 11, 2020

SELL
$106.92 - $132.43 $15,503 - $19,202
-145 Reduced 5.15%
2,671 $351,000
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $112,129 - $121,968
-1,050 Reduced 27.16%
2,816 $315,000
Q2 2019

Aug 08, 2019

BUY
$110.79 - $129.32 $5,539 - $6,466
50 Added 1.31%
3,866 $428,000
Q1 2019

May 08, 2019

BUY
$111.31 - $131.02 $177,539 - $208,976
1,595 Added 71.81%
3,816 $495,000
Q4 2018

Feb 04, 2019

BUY
$105.9 - $118.64 $13,661 - $15,304
129 Added 6.17%
2,221 $257,000
Q3 2018

Nov 05, 2018

BUY
$85.86 - $107.31 $179,619 - $224,492
2,092 New
2,092 $224,000
Q1 2018

May 07, 2018

SELL
$74.21 - $87.6 $198,214 - $233,979
-2,671 Closed
0 $0
Q4 2017

Feb 13, 2018

SELL
$81.94 - $87.89 $287,199 - $308,054
-3,505 Reduced 56.75%
2,671 $226,000
Q3 2017

Nov 02, 2017

BUY
$77.07 - $85.54 $5,780 - $6,415
75 Added 1.23%
6,176 $528,000
Q2 2017

Aug 11, 2017

BUY
N/A
6,101
6,101 $502,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Becker Capital Management Inc Portfolio

Follow Becker Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Becker Capital Management Inc with notifications on news.